I was named director of The Cancer Institute of New Jersey and associate dean for oncology programs in September 2008. Prior to that I served as the chief of the Division of Medical Oncology and associate director for clinical sciences for The Cancer Institute of New Jersey and originally joined CINJ in 1994. I am also a professor of medicine at UMDNJ-Robert Wood Johnson Medical School and a medical oncologist with a focus on prostate cancer research.
Working closely with experts across multi-disciplines including radiation and surgical oncologists, nurses and social workers in the Urologic Oncology Program, I provide patients with a comprehensive evaluation and help educate them about their disease so that they can make informed decisions about their treatment options. Some of these options may include clinical trials, some of which are only available at National Cancer Institute-designated Cancer Centers like The Cancer Institute of New Jersey.
I have served on multiple committees at the National Cancer Institute including the Genitourinary Committee and Investigational Drug Steering Committees, and have served as the chairman of the Eastern Cooperative Oncology Group. My participation on the Genitourinary Committee enabled me to develop clinical trials with novel agents for prostate cancer on a national level.
Currently I receive funding from the National Institutes of Health and the Department of Defense for laboratory and translational research focused on mechanisms of drug resistance in prostate cancer. I also am the principal investigator for The Cancer Institute of New Jersey on a national prostate cancer consortium of 13 NCI-designated Cancer Centers across the country engaged in innovative and collaborative research to tackle prostate cancer. This provides our prostate cancer patients with access to state-of-the-art treatment options.
I completed my undergraduate training at the University of Utah where I graduated Summa Cum Laude and earned my medical degree from the University of Utah School of Medicine. Following that, I completed my internal medicine residency at Duke University Medical Center and was an oncology and hematology Fellow at the University of Pennsylvania.
Prostate cancer and clinical trials
- Invited to serve as a member of the NCI Clinical Trials Working Group for a five year term
- Invited to serve as a member of the NCI Subcommittee: A Cancer Centers Initial Review Group for a term of four years
To schedule an appointment call 732-235-8515